Navigation Links
Selfish DNA and the Genetic Control of Vector-Borne Diseases
Date:11/20/2007

ghtly different mechanism involving clever molecular manipulations which result in the reduction of other genotypes. Recently, a synthetic form of one of these selfish elements, the Medea element, was created by researchers. This tame selfish element may be more tractable in the development of effectively modified mosquitoes, bringing researchers closer to the goal of reducing the transmission of pathogens by insect vectors.

To accomplish this goal, researchers working on the molecular biology of selfish DNA must combine forces with entomologists and population geneticists who study these same genes at the level of the organism or populations of organisms. This is a challenge because most individual researchers tend to interact only with others in their fields and often have only a superficial understanding and appreciation for work on other aspects of selfish genetic elements. In part this is because scientists from these different backgrounds do not often have an opportunity to interact and this hampers their ability develop fruitful collaborations.

To overcome this isolation, the organizers of this meeting are bringing together leading scientists working on this problem from different perspectives to exchange information and discuss new approaches for using selfish genetic elements to control vector-borne diseases. This kind of synthetic, cross-fertilization can lead to breakthroughs in research and advance the field by creating opportunities for new collaborations. The organizers hope to move the research forward in this field and shorten the time-line for producing a practical solution to controlling disease vectors.

Selfish DNA and the Genetic Control of Vector-Borne Diseases

WHEN: December 5-7, 2007

WHERE: National Evolutionary Synthesis Center (NESCent), Durham, NC, USA

ORGANIZERS: Fred Gould, North Carolina State University; Steven Sinkins, University of Oxford; Daniel Hartl, Harvard University
'/>"/>

Contact: Kristin Jenkins
kjenkins@nescent.org
919-668-4544
National Evolutionary Synthesis Center (NESCent)
Source:Eurekalert

Page: 1 2 3

Related biology news :

1. Does the desire to consume alcohol and tobacco come from our genetic makeup?
2. Diverse genetic abnormalities lead to NF-κB activation in multiple myeloma
3. Many parents at-risk for cancer disclose genetic test results to children
4. Genetics determine optimal drug dose of common anticoagulant
5. Claims of sex-related differences in genetic association studies often not properly validated
6. American College of Medical Genetics responds to new FDA labeling decision for warfarin
7. UNC study questions FDA genetic-screening guidelines for cancer drug
8. Genome study shines light on genetic link to height
9. Selexis Announces Advanced Approach to Maximize Power of Genetic Elements for Rapid Development of High Performance Cell Lines
10. Genes, Environment and Health Initiative invests in genetic studies, environmental monitoring
11. Rutgers Genetics receives $7.8 million for autism research
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/11/2015)... February 11, 2015 ... "Access Control Market by Product (Cards and Readers, Biometrics, ... Defense, Government, Industrial, Healthcare, Education) and By Geography - Global ... MarketsandMarkets, the Access Control Market is expected ... at a CAGR of 10.6% between 2014 ...
(Date:2/5/2015)... 5, 2015  Marken is starting its 35 th ... launched a new marketing campaign to solidify its place ... new campaign focuses on First as a ... The first headline in the series, ... with its client,s priorities. Marken recognizes the need to ...
(Date:2/5/2015)... -- New Market Research Reports Title Global ... 2020 has Been Added to GrandViewReseach.com Report Database ... reach USD 5.10 billion by 2020, according to a ... help identify the site of tissue damage in case ... in medical imaging applications. They have been extensively used ...
Breaking Biology News(10 mins):Access Control Market Worth $10.4 Billion by 2020 2Access Control Market Worth $10.4 Billion by 2020 3Access Control Market Worth $10.4 Billion by 2020 4Marken Launches New Patient-Centric Campaign 2IR Camera Market Worth $5.10 Billion By 2020: Grand View Research, Inc. 2IR Camera Market Worth $5.10 Billion By 2020: Grand View Research, Inc. 3
... book titles to real estate developments, it,s easier to find ... it. That,s why a Kansas State University geographer is ... who might be trying to work toward it. Her goal ... have to make decisions about what to sustain with the ...
... WASHINGTONThe Wilson Center,s Synthetic Biology project recently ... One will support a Transatlantic Exploratory Workshop on ... and Policy, and the other will support research ... explore emerging issues in synthetic biology. The ...
... Ariz. (Sept. 22, 2009) TGen Clinical Research Services ... clinical trial for a drug designed to combat adrenocortical ... the adrenal glands. TCRS is a strategic alliance ... Healthcare. Other than surgery, the only treatment for ...
Cached Biology News:K-State geographer working to clarify what sustainability really means to rural decision-makers 2Revolutionary drug could be new hope for adrenal cancer patients 2Revolutionary drug could be new hope for adrenal cancer patients 3
(Date:3/3/2015)... DIEGO , March 3, 2015  Neurocrine Biosciences, ... Kevin Gorman , President and Chief Executive Officer ... Global Healthcare Conference in Miami.   The ... 10:15am ET (7:15am PT).  The presentation will be webcast ... http://www.neurocrine.com .   Listeners are encouraged ...
(Date:3/3/2015)... 2015  Regenicin, Inc. (OTC Bulletin Board: ... of and commercialization of regenerative cell therapies to restore ... that it has received the final payment to conclude ... (OTC Bulletin Board: AMBS ). ... final payments due to Regenicin in the amount of ...
(Date:3/3/2015)... , March 3, 2015  Thingee Corporation, a ... be delivering a presentation entitled, "Technology Adoption: Making Reps, ... Thriving through Innovations and Technology ,  in ... 11 to 13, 2015. Audiences looking to learn how ... will want to be in the audience for the ...
(Date:3/3/2015)... (PRWEB) March 03, 2015 Genedata, ... drug discovery and life science research, today announced ... (TM) enterprise platform for use at Pfizer biopharma ... Europe. Genedata is supporting Pfizer’s global deployment and ... (GBT), Centers for Therapeutic Innovation (CTI), and Pharmaceutical ...
Breaking Biology Technology:Regenicin (RGIN) Receives $2.3 Million in Final Payment from Amarantus 2Regenicin (RGIN) Receives $2.3 Million in Final Payment from Amarantus 3Thingee to present at 11th Annual Synergistix Users Conference 2Genedata Biologics Licensed by Pfizer Inc. 2Genedata Biologics Licensed by Pfizer Inc. 3
... INTRODUCTION , ... which hydrolyze β -lactam antibiotics. The majority of β -lactamases produced ... to combating the serine active site β -lactamases is the use ... a β -lactam antibiotic 4 . , There is also a ...
... McGown, Ph.D. and Anna Lam, B.S., ... Molecular Devices Corporation, 8/99 , , INTRODUCTION ... use synthetic chromogenic or flu-orogenic peptide substrates. Enzyme selectivity is ... catalytic site of a particular enzyme. The chromophore or fluorophore ...
... Vronique Brechler, David Handfield, Martin Boissonneault, Esther Tremblay, ... Introduction , ... led to an unprecedented increase in both the number of compounds ... automated liquid handling and microplate assay systems has helped to meet ...
Cached Biology Technology:A Microtiter-based Assay for the Determination of ID50s of b-lactamase Inhibitors Employing Reporter Substrates Detected at UV or Visible Wavelengths (MaxLine Application Note #20) 2A Microtiter-based Assay for the Determination of ID50s of b-lactamase Inhibitors Employing Reporter Substrates Detected at UV or Visible Wavelengths (MaxLine Application Note #20) 3A Microtiter-based Assay for the Determination of ID50s of b-lactamase Inhibitors Employing Reporter Substrates Detected at UV or Visible Wavelengths (MaxLine Application Note #20) 4A Microtiter-based Assay for the Determination of ID50s of b-lactamase Inhibitors Employing Reporter Substrates Detected at UV or Visible Wavelengths (MaxLine Application Note #20) 5A Microtiter-based Assay for the Determination of ID50s of b-lactamase Inhibitors Employing Reporter Substrates Detected at UV or Visible Wavelengths (MaxLine Application Note #20) 6Fluorometric Protease Assays in the SpectraMax Gemini Microplate Spectrofluorometer: Example Using Caspase3 (MaxLine Application Note #35) 2Fluorometric Protease Assays in the SpectraMax Gemini Microplate Spectrofluorometer: Example Using Caspase3 (MaxLine Application Note #35) 3Fluorometric Protease Assays in the SpectraMax Gemini Microplate Spectrofluorometer: Example Using Caspase3 (MaxLine Application Note #35) 4Fluorometric Protease Assays in the SpectraMax Gemini Microplate Spectrofluorometer: Example Using Caspase3 (MaxLine Application Note #35) 5Fluorometric Protease Assays in the SpectraMax Gemini Microplate Spectrofluorometer: Example Using Caspase3 (MaxLine Application Note #35) 6Development of Radioligand Binding Assays for the Motilin Receptor Using ScreenReady Targets. 2Development of Radioligand Binding Assays for the Motilin Receptor Using ScreenReady Targets. 3Development of Radioligand Binding Assays for the Motilin Receptor Using ScreenReady Targets. 4Development of Radioligand Binding Assays for the Motilin Receptor Using ScreenReady Targets. 5
IMAGEQUANT 400 WKSTN, 1 EA. Category: ImageQuant CCD Imagers....
PAb to Hu-IFN-Alpha/Beta R2 [(IFNAR2) CD118], Rabbit Serum, neutralizing Binds to but does not neutralize human interferon alpha/beta receptor...
ANTI MYCOBACTERIUM TUBERCULOSIS...
ImageQuant 400, 1 EA. Category: ImageQuant CCD Imagers....
Biology Products: